Microbiological screening tests for SARS-CoV-2 in the first hour since the hospital admission: A reliable tool for enhancing the safety of pediatric care.
COVID-19
RT-PCR
SARS-CoV-2
hospital-acquired infection
risk management
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
06
2022
accepted:
12
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Since a significant proportion of SARS-CoV-2 infections occur within healthcare facilities, a multidisciplinary approach is required for careful and timely assessment of the risk of infection in asymptomatic patients or those whose COVID-19 diagnosis has not yet been made. The aim of this study was to investigate whether an adaptative model based on microbiological testing can represent a valid risk management strategy. We collected data from the risk management unit database of a 1,550-bed tertiary hospital (Fondazione Policlinico Gemelli IRCCS, Rome, Italy) concerning pediatric admissions to the Emergency Department (ED) from 1 March 2020 to 31 December 2021. The study period was subdivided in period A and period B according to the technique used for the microbiological screening, respectively reverse-transcription polymerase chain reaction (RT-PCR) and antigen-detection test. In Period A, 426 children (mean age: 6 years) underwent microbiological screening at the ED. The total number of molecular tests performed was 463. 459/463 tested negative at the molecular test. In Period B, 887 children (mean age: 6 years) underwent microbiological screening in the ED. The total number of molecular tests performed was 1,154. 1,117/1,154 tested negative at the molecular test. Neither in Period A nor in Period B hospital-acquired SARS-CoV-2 infections were reported. Despite high volumes, no cases of hospital-acquired SARS-CoV-2 infection have been reported. SARS-CoV-2 antigen-based tests can be used as a first-line option as they provide rapid results compared to RT-PCR, reducing the risk of infection in ED waiting rooms.
Identifiants
pubmed: 36147810
doi: 10.3389/fped.2022.966901
pmc: PMC9485667
doi:
Types de publication
Journal Article
Langues
eng
Pagination
966901Informations de copyright
Copyright © 2022 Vetrugno, Grassi, Clemente, Cazzato, Rossi, Grassi, Buonsenso, Filograna, Sanguinetti, Focardi, Valentini, Ozonoff, Pinchi and Oliva.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Patient Saf. 2020 Dec;16(4):e299-e302
pubmed: 32941344
Front Public Health. 2020 Jul 29;8:383
pubmed: 32850602
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705
pubmed: 33760236
Int J Legal Med. 2022 May;136(3):935-939
pubmed: 35072749
J Glob Health. 2020 Dec;10(2):021101
pubmed: 33312511
J Virol Methods. 2021 Feb;288:114024
pubmed: 33227341
Molecules. 2021 Jun 09;26(12):
pubmed: 34207756
Life Sci. 2020 Oct 1;258:118207
pubmed: 32777301
Front Med (Lausanne). 2022 Apr 07;9:870738
pubmed: 35463027
Biomarkers. 2021 May;26(3):213-220
pubmed: 33455451
Diagnostics (Basel). 2021 Jul 05;11(7):
pubmed: 34359294
Arch Pathol Lab Med. 2020 Sep 1;144(9):1048-1056
pubmed: 32383963
Biosensors (Basel). 2021 May 01;11(5):
pubmed: 34062874
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915975
Lancet. 2021 Sep 18;398(10305):1037-1038
pubmed: 34391505
Ir J Med Sci. 2021 May;190(2):461-468
pubmed: 32894436
J Clin Virol. 2020 Aug;129:104500
pubmed: 32585619
PLoS Med. 2021 Oct 12;18(10):e1003816
pubmed: 34637439
SN Compr Clin Med. 2020;2(11):1959-1969
pubmed: 32984767
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Healthcare (Basel). 2021 Sep 05;9(9):
pubmed: 34574937
Clin Chim Acta. 2021 May;516:1-7
pubmed: 33485902
J Clin Med. 2021 Jan 15;10(2):
pubmed: 33467628
Biosens Bioelectron. 2021 Jan 15;172:112752
pubmed: 33126180
Int J Mol Med. 2021 Jun;47(6):
pubmed: 33846767
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Lancet Infect Dis. 2021 Aug;21(8):1052-1053
pubmed: 33773617
Indian J Tuberc. 2020 Dec;67(4S):S163-S166
pubmed: 33308664
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1782-1784
pubmed: 34968376
J Virol Methods. 2021 Sep;295:114201
pubmed: 34058287
Virol J. 2020 Nov 13;17(1):177
pubmed: 33187528
Pediatr Infect Dis J. 2021 May 1;40(5):385-388
pubmed: 33605674